Compare MCRB & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCRB | FLXS |
|---|---|---|
| Founded | 2010 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 162.7M | 184.8M |
| IPO Year | 2015 | N/A |
| Metric | MCRB | FLXS |
|---|---|---|
| Price | $15.17 | $41.32 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $14.33 | N/A |
| AVG Volume (30 Days) | ★ 89.9K | 28.3K |
| Earning Date | 11-05-2025 | 02-02-2026 |
| Dividend Yield | N/A | ★ 1.95% |
| EPS Growth | N/A | ★ 64.53 |
| EPS | 0.62 | ★ 4.11 |
| Revenue | $351,000.00 | ★ $447,505,000.00 |
| Revenue This Year | N/A | $4.11 |
| Revenue Next Year | N/A | $3.04 |
| P/E Ratio | $24.71 | ★ $9.99 |
| Revenue Growth | N/A | ★ 6.00 |
| 52 Week Low | $6.53 | $29.38 |
| 52 Week High | $29.98 | $64.14 |
| Indicator | MCRB | FLXS |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 56.97 |
| Support Level | $14.03 | $40.00 |
| Resistance Level | $17.90 | $42.41 |
| Average True Range (ATR) | 0.94 | 0.99 |
| MACD | -0.18 | -0.15 |
| Stochastic Oscillator | 32.82 | 38.81 |
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.